The literature consistently highlights the beneficial effects of various H3R antagonists and inverse agonists in addressing cognitive damage in AD, PD, anxiety, schizophrenia, depression, and sleep disorders [4,99,168,169,170]. The gene discussed is HRH3; the disease is depressive symptom measurement.